Issa Shaza, Fayoud Haidar, Shaimardanova Alisa, Sufianov Albert, Sufianova Galina, Solovyeva Valeriya, Rizvanov Albert
Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.
Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Biomedicines. 2024 Aug 20;12(8):1906. doi: 10.3390/biomedicines12081906.
Hereditary neurodegenerative diseases (hNDDs) such as Alzheimer's, Parkinson's, Huntington's disease, and others are primarily characterized by their progressive nature, severely compromising both the cognitive and motor abilities of patients. The underlying genetic component in hNDDs contributes to disease risk, creating a complex genetic landscape. Considering the fact that growth factors play crucial roles in regulating cellular processes, such as proliferation, differentiation, and survival, they could have therapeutic potential for hNDDs, provided appropriate dosing and safe delivery approaches are ensured. This article presents a detailed overview of growth factors, and explores their therapeutic potential in treating hNDDs, emphasizing their roles in neuronal survival, growth, and synaptic plasticity. However, challenges such as proper dosing, delivery methods, and patient variability can hinder their clinical application.
遗传性神经退行性疾病(hNDDs),如阿尔茨海默病、帕金森病、亨廷顿病等,其主要特征是具有进行性,严重损害患者的认知和运动能力。hNDDs潜在的遗传因素会增加患病风险,形成复杂的遗传格局。鉴于生长因子在调节细胞增殖、分化和存活等细胞过程中发挥着关键作用,若能确保适当的剂量和安全的递送方法,它们可能对hNDDs具有治疗潜力。本文详细概述了生长因子,并探讨了它们在治疗hNDDs方面的治疗潜力,强调了它们在神经元存活、生长和突触可塑性中的作用。然而,诸如适当剂量、递送方法和患者个体差异等挑战可能会阻碍它们的临床应用。